Arrowhead Pharmaceuticals, Inc.

CAPTRUST FINANCIAL ADVISORS ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

17,644

Value ($000)

1,171

Weight

0.0%

2020 Q1 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	1,171	0.0%	17,644	12/31/2025
2025 Q3	11/19/2025	684	0.0%	19,822	9/30/2025
2025 Q2	8/15/2025	269	0.0%	17,039	6/30/2025
2025 Q1	5/15/2025	248	0.0%	19,434	3/31/2025
2024 Q4	2/14/2025	321	0.0%	17,074	12/31/2024
2024 Q3	11/14/2024	291	0.0%	15,039	9/30/2024
2023 Q4	2/14/2024	206	0.0%	6,748	12/31/2023
2022 Q2	8/23/2022	42	0.0%	1,201	6/30/2022
2022 Q1	5/16/2022	45	0.0%	981	3/31/2022
2021 Q4	2/14/2022	60	0.0%	909	12/31/2021
2021 Q3	11/16/2021	55	0.0%	874	9/30/2021
2021 Q2	8/16/2021	70	0.0%	844	6/30/2021
2021 Q1	5/17/2021	302	0.0%	4,557	3/31/2021
2020 Q4	2/16/2021	322	0.0%	4,200	12/31/2020
2020 Q3	11/17/2020	166	0.0%	3,700	9/30/2020
2020 Q2	8/14/2020	155	0.0%	3,500	6/30/2020
2020 Q1	5/15/2020	93	0.0%	3,500	3/31/2020